Assessment of the occurrence and factors influencing hepatitis B, hepatitis C, and liver damage in individuals with HIV undergoing antiretroviral treatment in Ghana's Upper East Region - Takeaways - MDSpire

Assessment of the occurrence and factors influencing hepatitis B, hepatitis C, and liver damage in individuals with HIV undergoing antiretroviral treatment in Ghana's Upper East Region

  • By

  • Francis Yennube Duut

  • Samuel Punignan Nfoke

  • Elvis Ayamga

  • Naja Kwayaja

  • Dodzi Kwaku Jnr Senoo

  • Godfred Agongo

  • James Abugri

  • Sylvester Donne Dassah

  • February 5, 2026

  • 0 min

Share

  • 1

    Hepatitis B and C co-infections significantly impact individuals with HIV, exacerbating liver damage and complicating antiretroviral therapy decisions.

  • 2

    In Ghana, approximately 13.6% of people living with HIV are co-infected with chronic hepatitis B, while hepatitis C co-infection rates are generally lower.

  • 3

    The study found high seroprevalence rates of HBV (15.6%) and HCV (8.4%) among PLHIV in Ghana's Upper East Region, highlighting the need for routine screening.

  • 4

    Antiretroviral therapy can lead to liver injury, necessitating careful selection of treatment regimens for co-infected patients to minimize hepatotoxicity.

  • 5

    The research aims to provide epidemiological data to improve HIV care practices and reduce liver-related morbidity in the Upper East Region of Ghana.

Original Source(s)

Assessment of the occurrence and factors influencing hepatitis B, hepatitis C, and liver damage in individuals with HIV undergoing antiretroviral treatment in Ghana's Upper East Region

  • by Francis Yennube Duut, Samuel Punignan Nfoke, Elvis Ayamga, Naja Kwayaja, Dodzi Kwaku Jnr Senoo, Godfred Agongo, James Abugri, Sylvester Donne Dassah

  • February 5, 2026

Related Content

Indiana community fights to keep needle exchange going after Trump order

Hepatitis C Co-infection Among Pregnant Women With Syphilis in West Virginia, 2019–2023

Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies